Compare CYTK & CUBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYTK | CUBE |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.6B |
| IPO Year | 2004 | 2004 |
| Metric | CYTK | CUBE |
|---|---|---|
| Price | $63.34 | $37.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $84.81 | $44.42 |
| AVG Volume (30 Days) | 1.8M | ★ 2.3M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.55 |
| Revenue | $87,211,000.00 | ★ $1,110,530,000.00 |
| Revenue This Year | $341.94 | $2.65 |
| Revenue Next Year | $75.44 | $2.55 |
| P/E Ratio | ★ N/A | $24.22 |
| Revenue Growth | ★ 2609.26 | 4.09 |
| 52 Week Low | $29.31 | $34.24 |
| 52 Week High | $70.98 | $44.13 |
| Indicator | CYTK | CUBE |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 47.97 |
| Support Level | $62.13 | $36.91 |
| Resistance Level | $65.88 | $37.79 |
| Average True Range (ATR) | 2.59 | 0.76 |
| MACD | 0.07 | -0.15 |
| Stochastic Oscillator | 54.84 | 12.57 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.